These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains. Tano Y, Shimizu H, Martin J, Nishimura Y, Simizu B, Miyamura T. Vaccine; 2007 Oct 10; 25(41):7041-6. PubMed ID: 17825459 [Abstract] [Full Text] [Related]
6. Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells. Haastrup E, Thierry-Carstensen B, Jensen AM, Stellfeld M, Heilmann C. Vaccine; 2004 Feb 25; 22(8):958-62. PubMed ID: 15161072 [Abstract] [Full Text] [Related]
8. 1,25-dihydroxyvitamin d3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice. Ivanov AP, Dragunsky EM, Chumakov KM. J Infect Dis; 2006 Feb 15; 193(4):598-600. PubMed ID: 16425140 [Abstract] [Full Text] [Related]
9. An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model. Bockstal V, Tiemessen MM, Achterberg R, Van Wordragen C, Knaapen AM, Serroyen J, Marissen WE, Schuitemaker H, Zahn R. Vaccine; 2018 Nov 12; 36(46):6979-6987. PubMed ID: 30314910 [Abstract] [Full Text] [Related]
10. Progress with inactivated poliovirus vaccines derived from the Sabin strains. Doi Y, Abe S, Yamamoto H, Horie H, Ohyama H, Satoh K, Tano Y, Ota Y, Miyazawa M, Wakabayashi K, Hashizume S. Dev Biol (Basel); 2001 Nov 12; 105():163-9. PubMed ID: 11763324 [Abstract] [Full Text] [Related]
11. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus. Yang C, Shi H, Zhou J, Liang Y, Xu H. Vaccine; 2009 Nov 05; 27(47):6558-63. PubMed ID: 19729087 [Abstract] [Full Text] [Related]
15. Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV. Sanders BP, Oakes Ide L, van Hoek V, Liu Y, Marissen W, Minor PD, Wimmer E, Schuitemaker H, Custers JH, Macadam A, Cello J, Edo-Matas D. Vaccine; 2015 Nov 27; 33(48):6611-6. PubMed ID: 26529068 [Abstract] [Full Text] [Related]
17. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age. Black S, Friedland LR, Ensor K, Weston WM, Howe B, Klein NP. Pediatr Infect Dis J; 2008 Apr 27; 27(4):341-6. PubMed ID: 18316985 [Abstract] [Full Text] [Related]
18. Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains. Martín J, Crossland G, Wood DJ, Minor PD. J Gen Virol; 2003 Jul 27; 84(Pt 7):1781-1788. PubMed ID: 12810872 [Abstract] [Full Text] [Related]